
Janus Henderson Global Life Sciences Fund Class C
JFNCX
Updated: 04/11/2026, 12:56:04
No historical data available
The fund endeavors to generate long-term capital appreciation. To achieve this, it typically commits at least 80% of its net assets, along with any borrowed capital for investment, to securities of companies its portfolio managers deem to be focused on life sciences. As a foundational aspect of its investment approach, the fund has a policy to generally deploy at least 25% of its total assets into companies formally categorized within the "life sciences" sector.
No summaries found.
- Share price
- $76.43
- Market cap
- $5.80B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 06/07/2009
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $76.34 – $76.43
- 52-week range
- $62.48 – $77.78
- 1-day performance
- 0.12%
- 1-year performance
- 22.33%
- Current drawdown (1Y)
- -1.74%
- CIK
- 0000277751
- CUSIP
- 471023473
- ISIN
- US4710234737
- Created
- 07/12/2025, 04:50:56
- Last update
- 04/11/2026, 12:56:04
Track Janus Henderson Global Life Sciences Fund Class C with an AI analyst
See which prediction-market events move JFNCX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.